Insys Therapeutics, Inc. (INSY) has 56 open-market insider trades by 13 insiders since 2013. The most active filer is Patrick Fourteau, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Michael L. Babich | Pres | — | 3 | $21.6M | 2015-09-22 |
| Larry Dillaha | Chief Medical Officer | — | 1 | $11.2M | 2014-03-05 |
| Patrick Fourteau | Dir | — | 13 | $4.6M | 2017-08-04 |
| Brian Tambi | Dir | — | 3 | $2.7M | 2018-05-10 |
| John N. Kapoor | CEOPresDir10% Owner | — | 5 | $2.4M | 2018-02-27 |
| Theodore H. Stanley | Dir | — | 11 | $1.9M | 2016-08-16 |
| JOHN N Kapoor TRUST DATED September 20 1989 | Dir10% Owner | — | 7 | $1.8M | 2017-08-11 |
| Steven J. Meyer | Dir | — | 5 | $1.7M | 2019-03-04 |
| Franc del Fosse | General Counsel | — | 1 | $345K | 2015-06-10 |
| Daniel Brennan | VP | — | 2 | $332K | 2016-08-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Brian Tambi | Director | Sell | $2.1M | 2018-05-10 |
| JOHN N Kapoor TRUST DATED September 20 1989 | Director & 10% Owner | Buy | $156K | 2017-08-11 |
| Saeed Motahari | President | Buy | $49K | 2017-08-10 |
| Saeed Motahari | CEO & President | Buy | $60K | 2017-06-14 |
| Rohit Vishnoi | Director | Buy | $57K | 2017-06-01 |
| Steven J. Meyer | Director | Buy | $98K |
Companies that share insiders with INSY, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2017-05-18 |
| Saeed Motahari | CEO & President | Buy | $54K | 2017-05-16 |
| Steven J. Meyer | Director | Buy | $108K | 2016-11-04 |
| Theodore H. Stanley | Director | Sell | $270K | 2016-08-16 |
| John N. Kapoor | CEO & President +2 | Buy | $106K | 2016-08-12 |
| JOHN N Kapoor TRUST DATED September 20 1989 | 10% | Buy | $106K | 2016-08-12 |
| Patrick Fourteau | Director | Sell | $277K | 2016-08-11 |
| Daniel Brennan | VP | Sell | $111K | 2016-08-09 |
| Daniel Brennan | Exec VP & Chf Operations Off. | Sell | $222K | 2016-08-09 |
| Theodore H. Stanley | Director | Sell | $260K | 2016-06-06 |